Share This
FivePrime Therapeutics Inc.
FivePrime Therapeutics, Inc. is a pre-clinical stage biotech company, discovering and developing innovative protein and antibody therapeutics. FivePrime is using its world-class discovery platform to build a strong pipeline that currently includes products in development for cancer and...
Learn more about FivePrime Therapeutics Inc. »
Add More Topics
Save this view to a base, or just for yourself.
8 Board Membership topics matching:
Filter this Collection
Gail Maderis
Gail Maderis brings over 20 years of management experience in healthcare to her position as President and CEO. Prior to joining FivePrime, she held various business development and general management positions at Genzyme Corporation, including...
Mark McDade
Mark McDade is Chief Executive Officer of PDL Biopharma. Prior to PDL, he served as CEO of Signature BioScience, Inc. and was previously a co-founder and director of Corixa Corporation, where he served as Chief Operating Officer from September...
R. Lee Douglas
Lee Douglas was a co-founder of COR Therapeutics, Inc. During his 10 years at COR, he served in a number of senior management positions, including COR's original CEO. Since 1998, Mr. Douglas has been an independent consultant to...
James C. Blair
Jim Blair has been a Partner of Domain Associates since its founding in 1985. He has over 35 years experience with venture and emerging growth companies. In the course of this experience, he has been involved with the creation and...
Brian Atwood
Brian Atwood co-founded Versant Ventures after spending four years at Brentwood Venture Capital where as a general partner he led investments in biotechnology, pharmaceuticals, and bioinformatics. He also has more than 15 years of operating...
Lewis T. Williams
Rusty Williams is the founder of FivePrime, serves as its Executive Chairman and leads its research and development efforts. Prior to founding FivePrime, Dr. Williams was Chief Scientific Officer and a member of the Board of Directors of Chiron...
Title:
Brook Byers
Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than forty new technology based ventures, over half of which have already become public companies. He formed the first Life Sciences practice group in...
Fred Cohen
Fred is a Managing Director at TPG (Texas Pacific Group) Ventures. He also retains a position as a Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco. Fred also serves as a member of the boards of...
